Raphael Pharmaceutical Inc. (RAPH)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$7,000
Stockholders' Equity
-$1.9M
Cash & Equivalents
$1,000
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Raphael Pharmaceutical Inc. reported net income of -$223,000 and total assets of $7,000. Every figure below is taken directly from Raphael Pharmaceutical Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025—-$1.3M
FY2024—-$1.5M
FY2023—-$1.3M
FY2022—-$3.4M
FY2021—-$1.6M
FY2020—-$718,000

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KSep 1, 2026on EDGAR ↗
10-QAug 14, 2026on EDGAR ↗
8-KJul 17, 2026on EDGAR ↗
10-QMay 14, 2026on EDGAR ↗
10-KMar 31, 2026on EDGAR ↗
8-KMar 24, 2026on EDGAR ↗
10-QNov 13, 2025on EDGAR ↗
10-QAug 13, 2025on EDGAR ↗
8-KAug 11, 2025on EDGAR ↗
8-KAug 11, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$7,000source ↗
Stockholders’ Equity-$1.9Msource ↗
Cash & Equivalents$1,000source ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$223,000source ↗
Operating Income-$199,000source ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$40,000source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$0.01source ↗
EPS (basic)$0.01source ↗
Shares Outstanding20.2Msource ↗
Cash from Operations$0source ↗
Cash from Financing—source ↗
Cash from Investing—source ↗

Restatement history

Point-in-time

7 of 111 annual fact-keys were materially restated between filings: what Raphael Pharmaceutical Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

See the restatement detail →

Deeper fundamentals

A free API key reaches RAPH’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/RAPH

MCP tool: get_sec_fundamentals ticker=RAPH

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/RAPH/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=RAPH as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/RAPH/history

MCP tool: get_fundamentals_history ticker=RAPH

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/RAPH

MCP tool: get_financial_health ticker=RAPH

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.